This announcement is a separate document:
大幸薬品：役員報酬減額の継続に関するお知らせ
Taiko Pharmaceutical: Notice Concerning Continued Reduction in Executive Remuneration
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.